Agenda
Thursday, May 1, 2025
KEYNOTE | PLENARY SESSIONS | CONCURRENT SESSIONS | EXHIBITS
Check-In
Breakfast, Visit Exhibit Hall and View Posters
Welcome Remarks
Carl H. June, MD | Penn Medicine | Symposium Co-Chair
J. Larry Jameson, MD, PhD | President of the University of Pennsylvania
KEYNOTE PANEL: Closing the Gap: Philanthropy's Role in Equitable CAR-T Access
Moderators:
Carl H. June, MD | Penn Medicine | Symposium Co-Chair
David L. Porter, MD | Penn Medicine | Symposium Co-Chair
Panel:
Valerie A. Arkoosh, MD, MPH | Pennsylvania Secretary of Human Services
Tricia A. Bruning | Penn Medicine Development
Lee Greenberger, PhD | LMG Bio1 Consulting
Stephen Kelly | CHOP
Tom Whitehead | Emily Whitehead Foundation
PLENARY SESSION 1: Risk and Cost vs. Reward and Benefit for Cell and Gene Therapies
Moderator: Stephan A. Grupp, MD, PhD | Children’s Hospital of Philadelphia | Symposium Co-Chair
Balancing CAR T Promise and Rare Events: Precision, doubt, and assessing risk
Bruce L. Levine, PhD | Penn Medicine | Symposium Co-Chair
TBA
Scott McGoohan, JD | Vertex
Immune Reconstitution after CAR-T: restoration, renewal, or beyond repair?
Stephen J. Schuster, MD | Penn Medicine
Discussion
Oral Presentation Winner
PLENARY SESSION 2: Leadership in Cell and Gene Therapies: The XX Factor
Moderator: Amanda Finck, BS | Penn Medicine
Leading the Charge For In Vivo Cell Therapy for The Treatment of Autoimmune Disorders
Laura Shawver, PhD | Capstan Therapeutics
Harnessing the Tumor Microenvironment by Genome Editing of T Cells
Chiara Bonini, MD | Vita-Salute San Raffaele University
CAR-T Trailblazers: Grand Adventures and the Power of Women Leadership in Cell and Gene Therapy
Kristen M. Hege, MD | Adaptimmune, EvolveImmune, Kelonia, KSQ, Mersana
Enhancing CAR T Cell Therapy for Pancreatic Cancer
M. Angela Aznar Gomez, PhD | Penn Medicine | The Muriel Joan Drew Hege, MD, Fund Oral Abstract Winner
Panel Discussion
CONCURRENT SESSION I
There are a total of 6 tracks. Scroll left and right to view all tracks.
Track 1 Pediatric Medical Care
Track 2 Clinical & Business Operations
Track 3 Nursing Keynotes
Track 4 The Next Disruptions in Cell and Gene Therapy: Hot Topics Lightning Talks from Muriel Joan Drew Hege Fund Scholars
Track 5 Commercial Partnering & Creating Products for Patients
Track 6 Expanding Access While Maintaining Quality: Going where no CAR T Cell has gone before
Track 1 Pediatric Medical Care 11:20 am EDT
All speakers from Children’s Hospital of Philadelphia
Moderator:
Stephan Grupp, MD, PhD
Emerging Gene Therapies for Inherited Bone Marrow Failure Syndromes
Julia T. Warren, MD, PhD
Immune Related Adverse Events of CART: What can we learn from pediatric B-ALL?
Caroline Diorio, MD, FRCPC, FAAP
Leveraging Cell Therapies to Treat Autoimmunity in Pediatric Patients
Caitlin Elgarten, MD, MSCE
Panel Discussion
Track 2 Clinical & Business Operations 11:20 am EDT
Moderators:
Mark Duckworth
CHOP
Robert (Robb) E. Richards, MS, MBA
Penn Medicine
Welcome
Legal Considerations for Cell and Gene Therapies
Denene M. Wambach, Esq
Penn Medicine
Q&A
Data Science in Cell Therapy: From collection to dissemination
Lindsey MacDonald MSN, MBA, RN, OCN
Penn Medicine
Chris Catania, MPH
Penn Medicine
Q&A
Collaborating for Success: A Nurse and Systems Analyst Perspective on Implementing the Epic Cell Therapy Module at CHOP
Roni Devassy, BS
CHOP
Ryan Burke, BSN, RN, CPHON, BMTCN
CHOP
Q&A
Track 3 Nursing Keynotes 11:20 am EDT
Moderators:
Anna Sparrow, MSN, MPH,RN
Heather Difilippo, CRNP
Special Welcome Remarks
KEYNOTES
Creating A Space for All: The Pursuit of Belonging
Hope Heffner-Solimeo, MA, ATR-BC, LPC
CHOP
Afami-cel for Synovial Sarcoma: the first approved TCR therapy
Daniel Lefler, MD
Penn Medicine
Panel Discussion
Katherine Ebby, MSN, RN, CPHON
CHOP
Eleni Hindle, BSN, RN, CPHON
CHOP
Selina Plummersturgis, BSN, RN
CHOP
Marissa Zangardi, BSN, RN, CPN
CHOP
Track 4 The Next Disruptions in Cell and Gene Therapy: Hot Topics Lightning Talks from Muriel Joan Drew Hege Fund Scholars 11:20 am EDT
Moderator:
Kristen M. Hege,MD
Adaptimmune, EvolveImmune, Kelonia, KSQ, Mersana
Center for Cellular Immunotherapies
All speakers are Muriel Joan Drew Hege Fund awardees
IL-9 Redirects CAR T Cell Fate, Enhancing Efficacy Against Solid Tumors
Sofia Castelli, PhD
Transient overexpression of IKZF1 enhances memory precursor phenotype in CAR-T cells
Sisi Chen, PhD
Clinical Applications of CAR T Cells in Hematologic Malignancies
Francesca Costabile, MSc, PhD
Overcoming Resistance; Deciphering the Glycan and Protein Interactome of Siglec-15: Unraveling its Role in Tumor-Associated Immunosuppression
Nohelly Derosiers, BE
Gene Therapy IND's and Regulatory Considerations
Laura Garcia Gerique, PhD
T Cell Fitness
Julia Han Noll, MS
p:Hishing for T cells: Using ‘chimeric antigen-presenting’ (CAP) T cells to target and eliminate antigen-specific T cell populations
Kaitlin A. Read, PhD
Allogeneic B7H3-redirected invariant NKT cells for off-the-shelf CAR immunotherapy of human and canine solid tumors
Antonia Rotolo, MD, PhD
Novel CAR T Cells for Prostate Cancer
Nour Shobaki, PharmD, PhD
Unconventional CAR's
Heather Sosnoski, BS
Q&A Discussion
Track 5 Commercial Partnering & Creating Products for Patients 11:20 am EDT
Moderator:
John Swartley, MBA, PhD
Penn Medicine
Workshop on Filing, Partnering, and Licensing Cell and Gene Therapy Intellectual Property
Panel Discussion
Mark Engleka, PhD
Penn Medicine
Tess Cameron, BA
RA Capital Management
Mir Masud-Elias, JD, MBE
Arnold & Porter
Track 6 Expanding Access While Maintaining Quality: Going where no CAR T Cell has gone before 11:20 am EDT
Moderator:
David L. Porter, MD
Penn Medicine
Expanding Access to Cell Therapies
Steven Devine, MD
National Marrow Donor Program (NMDP) /Be The Match
Discussion
Accelerating Global Access to Point of Care Cell Therapy
Stephan Kadauke, MD, PhD
Children’s Hospital of Philadelphia
Discussion
Quality Program Considerations for Cell Therapies Outside Heme Malignancies
PANEL:
Jenna Fetters MSHS, MLS (ASCP)
Penn Medicine
Victoria Collier, RN, BSN
Children's Hospital of Philadelphia
Becca Pesce-Noga, MS, CSSBB
Penn Medicine
LUNCH BREAK
Lunch | Visit Exhibits
CONCURRENT SESSION II
There are a total of 6 tracks. Scroll left and right to view all tracks.
Track 1 Pediatric Nursing Care
Track 2 Clinical & Business Operations
Track 3 Adult Nursing Care
Track 4 Hot Topics in Cell Therapies
Track 5 Commercial Partnering & Creating Products for Patients
Track 6 Expanding Access While Maintaining Quality: Going where no CAR T Cell has gone before
Track 1 Pediatric Nursing Care 1:30 pm EDT
All speakers from Children’s Hospital of Philadelphia
Moderators:
Diane Baniewicz MSN, CPNP
Samantha Barone MSN, CPNP-AC, CPHON
Description
- Implement evidence-based strategies to improve outcomes for patients
- Foster Interdisciplinary collaboration
- Effective communication among healthcare providers to improve patient care
- Explore emerging technologies and therapies
Toxicity Management
Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis Syndrome with CAR 19/22
Colleen Callahan, RN, MSN, CRNP
Mackenzie Stewart, CPNP-AC
Q&A
Improving Patient Partnership in Care
Implementation and Compliance with ICE scores in AYA patients post-CART
Katie A. Smith, DNP, MPH, RN, ACCNS-P, CPN, CHES
Anna Sparrow, MSN, MPH,RN
All Smiles for Clabsi Prevention: Improving Oral Care Completion on the Inpatient Oncology and Blood and Marrow Transplant Units
Catherine Aronowitz, CPN, CPHON
Q&A
Improving Provider Practice
Teamwork Makes the Marrow Work: Interprofessional Rounds on Inpatient Oncology and Blood and Marrow Transplant Units
Emily Roth, BSN, RN, CPN, CPHON
Sara Gunnoe, MPAS, PA-C
BMT Bootcamp: Education and training best practices for new BMT nurses
Ryan Burke, BSN, RN, CPHON, BMTCN
Megan Atkinson, BS, CHTC
Q&A
Track 2 Clinical & Business Operations 1:30 pm EDT
Moderators:
Mark Duckworth
CHOP
Robert (Robb) E. Richards, MS, MBA
Penn Medicine
Panel Discussion: From Coverage Policies to Prior Authorization: Financial Clearance for Cell and Gene Therapies
Claire White, MSN, RN
CHOP
Q&A
Blueprint for Success: Constructing a Unified Approach for the Future of Cell & Gene Therapy
Kaitlyn Lyons, MBA
Penn Medicine
Q&A
Track 3 Adult Nursing Care 1:30 pm EDT
All speakers from Penn Medicine
Moderators:
Heather Difilippo, CRNP
Patricia Mangan, RN, MSN, CRNP, APRN-BC
CART T Cell Therapy and Bispecifics for Multiple Myeloma
Patricia Mangan, RN, MSN, CRNP, APRN-BC
Overcoming Challenges and Complexities for Cell Therapy Coordinators
Matthew P. Casazza, RN
Natalie K. Stefano, RN
Harnessing EPIC for Cell Therapy Workflows and Data Management
Lindsey MacDonald MSN, MBA, RN, OCN
Elizabeth A. Weber, RN, BSN
TIL therapy and inpatient process management of infusion and IL2 toxicities
Lauren B. Hollander, NP
Rachel E. Hartman, PharmD
Panel Discussion
Track 4 Hot Topics in Cell Therapies 1:30 pm EDT
Moderator:
Elizabeth O. Hexner, MD
Penn Medicine
Lessons from spatial biology on CAR HLH/MAS
Andrew J. Rech, MD, PhD
Penn Medicine
Prostate Cancer
Naomi B. Haas, MD
Penn Medicine
Cytokine Biology behind CAR T toxicity and patient management
David T. Teachey, MD
CHOP
Panel Discussion
Track 5 Commercial Partnering & Creating Products for Patients 1:30 pm EDT
Moderator:
Audrey E. Greenberg, CPA, MBA
Discovery Labs Center for Breakthrough Medicines
Amplifying the Academia and Industry Ecosystem in Cellicon Valley
Panel:
R. Carter Caldwell, MBA
Penn Medicine
Jen Gilburg
Pennsylvania Department of Community and Economic Development
John Grady, MPA
Wexford Science & Technology
Track 6 Expanding Access While Maintaining Quality: Going where no CAR T Cell has gone before 1:30 pm EDT
Moderator:
Zev Binder, MD, PhD
Penn Medicine
LATE BREAKERS
Cell Therapies in Brain Cancer
Donald M. O'Rourke, MD
Penn Medicine
Hideho Okada, MD, PhD
University of California San Francisco
Q&A
BREAK
VISIT EXHIBITS